CEOs in the Sweet Spot

Amid a spate of high-level shakeups, these chief executives can point to five years of strong returns on their watch

Slide Show >>

Chief executives have been an embattled group lately. Bristol-Myers Squibb (BMY), Ford (F) and Viacom (VIA, VIA.B) each replaced their top executives in recent days. Last week, Five for the Money looked at CEOs whose corner offices could be vulnerable (see, 9/7/06, "CEOs in the Hot Seat"). This week, it's the sunnier side of the suite: CEOs basking in the glow of torrid stock performance.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.